There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CureVac (CVAC – Research Report) and GE Healthcare Technologies Inc (GEHC – Research Report) with bullish sentiments.
CureVac (CVAC)
In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on CureVac, with a price target of $16.00. The company’s shares closed last Thursday at $3.65.
According to TipRanks.com, Buchanan has 0 stars on 0-5 stars ranking scale with an average return of
CureVac has an analyst consensus of Hold, with a price target consensus of $9.25.
See the top stocks recommended by analysts >>
GE Healthcare Technologies Inc (GEHC)
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc, with a price target of $110.00. The company’s shares closed last Thursday at $93.65, close to its 52-week high of $94.55.
According to TipRanks.com, Wuensch is a 5-star analyst with an average return of
Currently, the analyst consensus on GE Healthcare Technologies Inc is a Strong Buy with an average price target of $101.22, which is a 12.5% upside from current levels. In a report issued on February 4, BTIG also maintained a Buy rating on the stock with a $99.00 price target.
Read More on CVAC:
